Inhibition of anthracycline semiquinone formation by ICRF-187 (dexrazoxane) in cells

Free Radic Biol Med. 1996;20(7):905-14. doi: 10.1016/0891-5849(95)02188-4.

Abstract

The formation of semiquinone free radicals of doxorubicin, epirubicin, daunorubicin, and idarubicin was measured by electron paramagnetic resonance (EPR) spectroscopy in hypoxic suspensions of chinese hamster ovary (CHO) cells. The amount of semiquinone produced was in the order idarubicin >> doxorubicin > daunorubicin > epirubicin. The idarubicin semiquinone signal was both the fastest to be formed and to decay. Idarubicin, which was the most lipophilic of the anthracyclines studied, also displayed the fastest fluorescence-measured cellular uptake of drug. Thus, it was concluded that semiquinone formation was dependent upon the rate of cellular uptake. Lysed cell suspensions were also shown to be capable of producing the doxorubicin semiquinone in the presence of added NADPH. The cardioprotective agent dexrazoxane (ICRF-187) was observed to decrease the amount of doxorubicin semiquinone observed in cell suspensions. Dexrazoxane also decreased the amount of doxorubicin semiquinone observed in the NADPH-lysed cell suspension mixture. Neither bipyridine nor deferoxamine decreased NADPH-dependent doxorubicin semiquinone formation. These results suggest that dexrazoxane does not decrease doxorubicin semiquinone formation through an iron complex formed from hydrolyzed dexrazoxane. Dexrazoxane may be inhibiting an NADPH-dependent enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / chemistry*
  • CHO Cells
  • Cardiovascular Agents / pharmacology*
  • Cell Survival
  • Cricetinae
  • Drug Evaluation, Preclinical
  • Electron Spin Resonance Spectroscopy
  • Free Radicals
  • Molecular Structure
  • Quinones / chemistry*
  • Razoxane / pharmacology*
  • Spectrometry, Fluorescence

Substances

  • Antibiotics, Antineoplastic
  • Cardiovascular Agents
  • Free Radicals
  • Quinones
  • Razoxane